Quaker Chemical (NYSE:KWR) Price Target Lowered to $182.00 at Deutsche Bank Aktiengesellschaft

Quaker Chemical (NYSE:KWR) had its price objective reduced by Deutsche Bank Aktiengesellschaft from $190.00 to $182.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have a buy rating on the specialty chemicals company’s stock.

Several other research firms have also recently weighed in on KWR. Royal Bank of Canada decreased their price objective on shares of Quaker Chemical from $220.00 to $195.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. StockNews.com raised shares of Quaker Chemical from a “hold” rating to a “buy” rating in a report on Tuesday, October 29th.

Quaker Chemical Stock Up 12.2 %

Shares of Quaker Chemical stock opened at $180.23 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.88 and a current ratio of 2.54. The stock has a market capitalization of $3.21 billion, a PE ratio of 26.43, a price-to-earnings-growth ratio of 1.98 and a beta of 1.38. Quaker Chemical has a 52-week low of $151.31 and a 52-week high of $221.94. The company has a 50-day simple moving average of $162.90 and a two-hundred day simple moving average of $171.70.

Quaker Chemical (NYSE:KWR) last released its quarterly earnings data on Thursday, October 31st. The specialty chemicals company reported $1.89 earnings per share for the quarter, missing the consensus estimate of $2.08 by ($0.19). Quaker Chemical had a net margin of 6.58% and a return on equity of 10.10%. The company had revenue of $462.27 million for the quarter, compared to analysts’ expectations of $469.17 million. During the same period in the previous year, the firm earned $2.05 earnings per share. The firm’s revenue for the quarter was down 5.8% on a year-over-year basis. On average, analysts anticipate that Quaker Chemical will post 7.88 EPS for the current fiscal year.

Hedge Funds Weigh In On Quaker Chemical

Institutional investors have recently bought and sold shares of the stock. Lord Abbett & CO. LLC purchased a new position in Quaker Chemical during the first quarter valued at $5,082,000. 1832 Asset Management L.P. grew its stake in Quaker Chemical by 46.3% during the first quarter. 1832 Asset Management L.P. now owns 32,570 shares of the specialty chemicals company’s stock valued at $6,685,000 after acquiring an additional 10,310 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Quaker Chemical by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 108,122 shares of the specialty chemicals company’s stock valued at $22,193,000 after acquiring an additional 3,441 shares in the last quarter. Mutual of America Capital Management LLC grew its stake in Quaker Chemical by 64.1% during the first quarter. Mutual of America Capital Management LLC now owns 24,419 shares of the specialty chemicals company’s stock valued at $5,012,000 after acquiring an additional 9,535 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its position in Quaker Chemical by 374.3% during the second quarter. Harbor Capital Advisors Inc. now owns 4,183 shares of the specialty chemicals company’s stock valued at $710,000 after purchasing an additional 3,301 shares during the last quarter. 77.46% of the stock is owned by hedge funds and other institutional investors.

Quaker Chemical Company Profile

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.